Important Notice Regarding Inveltys

Posted in Latest News on February 11, 2019.

During the February 8, 2019 Board of Optometry meeting, the board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002, F.A.C. Formulary of Topical Ocular Pharmaceutical Agents.

Important note: At this time, Inveltys cannot be prescribed by certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and Inveltys may be prescribed by certified optometrists at that time.



More Latest News

Topical Ocular Pharmaceutical Agents added to Formulary
September 1, 2021

The Board of Optometry has added the following Topical Ocular Pharmaceutical Agents to the formulary… Continue reading


Newly Licensed Florida Practitioners Search Tool
July 29, 2021

Click here to access data on recently licensed Health Care Practitioners and Facilities
  Continue reading